ConductScience.org, home

Paper657163

Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice.

Pacciarini MA and 5 others. Cancer Treat Rep, 1978. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice. Papers, record 657163. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/657163

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
1.73
iCite
Revised in PubMed
2013-11-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pacciarini MAM A
2Barbieri BB
3Colombo TT
4Broggini MM
5Garattini SS
6Donelli MGM G

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DoxorubicinMajor topic
Animals
Daunorubicin
Drug Administration Schedule
Female
Kinetics
Male
Mammary Neoplasms, Experimental
Mice
Mice, Inbred C3H
Mice, Inbred C57BL
Neoplasms, Experimental

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
36813809In vitro to clinical translational pharmacokinetic/pharmacodynamic modeling of doxorubicin (DOX) and dexrazoxane (DEX) interactions: Safety assessment and optimization.Sci Rep2023https://conductscience.org/library/papers/36813809PubMed
32892667The effect of injected dose on localized tumor accumulation and cardiac uptake of doxorubicin in a Vx2 rabbit tumor model using MR-HIFU mild hyperthermia and thermosensitive liposomes.Int J Hyperthermia2020https://conductscience.org/library/papers/32892667PubMed
32410142Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment.Heart Fail Rev2021https://conductscience.org/library/papers/32410142PubMed
31187890Doxorubicin-Induced Cardiomyopathy in Children.Compr Physiol2019https://conductscience.org/library/papers/31187890PubMed
26933263Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.Can Vet J2016https://conductscience.org/library/papers/26933263PubMed
25962976Cardiotoxicity of anticancer treatments.Nat Rev Cardiol2015https://conductscience.org/library/papers/25962976PubMed
8462124Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8462124PubMed
7426313Dependence of the cytostatic effect of adriamycin on drug concenration and exposure time in vitro.Br J Cancer1980https://conductscience.org/library/papers/7426313PubMed
7261254Doxorubicin pharmacokinetics after intravenous and intraperitoneal administration in the nude mouse.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7261254PubMed
6688382Influence of scheduling on therapeutic and toxic effect of AMSA in Lewis lung carcinoma.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6688382PubMed
3062572Continuous infusion of low-dose doxorubicin, epirubicin and mitoxantrone in cancer chemotherapy: a review.Pharm Weekbl Sci1988https://conductscience.org/library/papers/3062572PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/657163

GET https://conductscience.org/api/papers/v1/657163/authors